Is BSX or CAH cheaper?

On trailing earnings, BSX is cheaper: BSX trades at a 19.71 P/E and CAH at 34.62.

Which has grown faster, BSX or CAH?

Over the past five years, BSX grew revenue faster — BSX at a 15.29% CAGR versus CAH at 9.86%.

Does BSX or CAH pay a bigger dividend?

CAH pays a dividend (0.90% yield) while BSX does not currently pay one.

Is BSX or CAH more profitable?

BSX runs the higher net margin — BSX at 17.24% versus CAH at 0.62%.

Which has been the better investment, BSX or CAH?

Over the past 10-year, CAH delivered the higher annualized total return — BSX at 7.47% versus CAH at 14.76%. Past performance doesn't predict future results.

Boston Scientific Corporation (BSX) vs Cardinal Health, Inc. (CAH)

BSX leads on 8 of 15 compared metrics.

A side-by-side comparison of Boston Scientific Corporation and Cardinal Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 17, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

BSX

Boston Scientific Corporation

$69.74B

$46.92Healthcare

CAH

Cardinal Health, Inc.

$53.55B

$226.40Healthcare

Total return — BSX vs CAH

growth of $100 · last 30y

BSX +372.2%CAH +932.3%CAH compounded faster

BSX CAH

BSX vs CAH: by the numbers

•BSX is the larger company ($69.74B vs $53.55B market cap).
•BSX trades at the lower earnings multiple (19.71 vs 34.62 P/E).
•BSX converts more revenue to profit (17.24% vs 0.62% net margin).
•BSX grew revenue faster over the past five years (15.29% vs 9.86% CAGR).
•CAH pays a dividend (0.90% yield) while BSX does not currently pay one.

Which is better, BSX or CAH?

Metric tally: BSX 8 · CAH 7

It depends on what you're optimizing for:

ValueBSX(lower P/E)

GrowthBSX(faster 5Y revenue CAGR)

QualityCAH(higher ROIC)

Metrics side by side

Valuation

Metric	BSX	CAH
P/E ratio	19.71●	34.62
Forward P/E	12.60●	18.86
P/S ratio	3.40	0.21●
P/B ratio	2.71	—
PEG ratio	0.88	0.30●
EV / EBITDA	14.07●	19.30
FCF yield	4.91%	8.22%●

Profitability

Metric	BSX	CAH
Gross margin	70.41%●	3.68%
Operating margin	20.12%●	0.92%
Net margin	17.24%●	0.62%
ROE	13.74%●	-56.13%
ROIC	8.78%	11.37%●

Dividends

Metric	BSX	CAH
Dividend yield	—	0.90%
Payout ratio	—	31.52%

Growth (annualized)

Metric	BSX	CAH
Revenue CAGR (5Y)	15.29%●	9.86%
EPS CAGR (5Y)	-8.67%	6.11%●
FCF CAGR (5Y)	19.89%	22.47%●
Total return CAGR (5Y)	1.86%	34.89%●

Frequently asked

Which is better, BSX or CAH?: It depends on your goal. value: BSX (lower P/E); growth: BSX (faster 5Y revenue CAGR); quality: CAH (higher ROIC). Across all compared metrics, BSX leads 8 to 7.
Is BSX or CAH cheaper?: On trailing earnings, BSX is cheaper: BSX trades at a 19.71 P/E and CAH at 34.62.
Which has grown faster, BSX or CAH?: Over the past five years, BSX grew revenue faster — BSX at a 15.29% CAGR versus CAH at 9.86%.
Does BSX or CAH pay a bigger dividend?: CAH pays a dividend (0.90% yield) while BSX does not currently pay one.
Is BSX or CAH more profitable?: BSX runs the higher net margin — BSX at 17.24% versus CAH at 0.62%.
Which has been the better investment, BSX or CAH?: Over the past 10-year, CAH delivered the higher annualized total return — BSX at 7.47% versus CAH at 14.76%. Past performance doesn't predict future results.

Go deeper

Full BSX analysis Full CAH analysis Interactive comparison tool

Dig into the metrics

Boston Scientific P/E ratio Cardinal Health P/E ratio Boston Scientific dividend yield Cardinal Health dividend yield Boston Scientific ROE Cardinal Health ROE Boston Scientific operating margin Cardinal Health operating margin Boston Scientific revenue growth Cardinal Health revenue growth Boston Scientific free cash flow Cardinal Health free cash flow

Boston Scientific & Cardinal Health appear in these rankings

Dividend Aristocrats Fastest Revenue Growth Stocks Highest FCF Yield Stocks Best 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 17, 2026.